Brief: Fulgent Genetics Q4 Revenue USD 70.505 Million
28/02/2024 12:00
Feb 28 (Reuters) - Fulgent Genetics Q4 operating income USD -151.121 million. * Q4 gross profit USD 25.229 million * Q4 pretax profit USD -145.196 million * Q4 operating expenses USD 176.35 million * Q4 core revenue USD 66.5 million * Q4 adjusted EBITDA USD -6.8 million
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview